A Two-Arm Study Evaluation H.P. Acthar Injection Gel in Treatment of Chronic Migraines
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Frederick G Freitag, M.D.
Baylor Health Care System
Principal Investigator - John F Rothrock, M.D.
Renown Institute for Neurosciences
Principal Investigator - Laszlo L Mechtler, M.D.
Dent Neurologic Institute
Principal Investigator - Roger K Cady, M.D.
Clinvest
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
4 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Clinvest/a Division of Banyan Group, Inc.
Springfield, Missouri, United States
- Renown Institute of Neurosciences
Reno, Nevada, United States
- Dent Neurologic Institute
Amherst, New York, United States
- Baylor University Medical Center
Dallas, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Apr 2013
- Primary completion
- 31 Dec 2014
- Completion
- 30 Nov 2015
- Last update posted
- 26 Jul 2018
- Registered enrollment
- 20
- Registry id
- NCT01813591
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.